Developer docs
API playgroundTry for free, no card

Search company profiles

Candesic

Full company profile

uuid000aasx

Namestring
Candesic
Legal namestring
Candesic Limited
Websiteurl
candesic.com
Company typeenum
Private
Founded yearint
2002
Descriptiontext

Candesic is a London-headquartered, healthcare-specialist strategy consulting firm founded in 2002 by Dr Leonid Shapiro (formerly of McKinsey & Company). It serves three primary client segments — corporates and operators (from early-stage startups to global multinationals), investors across the investment lifecycle, and public sector organisations — across UK, EMEA, North America, and selected international markets. Services span strategic consulting (corporate/divisional strategy, growth roadmaps, M&A, pricing, regulatory), commercial due diligence for buy-side and sell-side transactions, scientific/clinical/operational due diligence, operations and clinical quality advisory, and digital/AI consulting.

The firm differentiates itself through a multidisciplinary team of ~40 professionals combining medical doctors, PhDs, and MBAs with international backgrounds, supported by in-house data scientists and programmers. Its methodology relies on creating proprietary primary datasets via Freedom of Information requests, panel surveys, and first-hand market information, and on a curated network of external thought leaders. It has delivered 700+ assignments over 20+ years and maintains offices in London and New York. The firm is independent and privately held (Candesic Limited, UK company number 11391257), with no disclosed institutional investors or parent entity.

Short descriptiontext

Candesic is an independent London-headquartered healthcare strategy consultancy serving corporates, investors, and public sector organisations with strategic advisory, commercial due diligence, and digital/AI consulting, delivered by a ~40-person team of doctors, PhDs, and MBAs.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
51–100
akta.pro rankint
HeadquartersLondon, United Kingdom
HQ citystring
London
HQ countrystring
United Kingdom
HQ regionstring
Europe
Markets served

Serves global market

Offices2 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
healthcare consulting, commercial due diligence, strategic advisory services, life sciences consulting, digital health consulting
Industry1 code
PRIMARYBPAHADAN
Distressed M&A & Special Situations Advisory
NAICS code2 codes
  • Management Consulting Services54161
  • Management, Scientific, and Technical Consulting Services5416
SIC code1 code
  • Services-Management Consulting Services8742
Product category
Healthcare Management Consulting
Social media profiles2 records
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model1 record
1Strategic Consulting Services
TypeProfessional Services
Description

Fees for strategic consulting including setting corporate and divisional strategy, developing business plans, reviewing organic and inorganic growth road-maps, analysing product positioning and providing competitive benchmarking. Services are provided to corporate teams, investors, and public sector organisations.

candesic.com
Marketing channels5 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels1 record

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Personnel, Operations, Marketing or Sales, Technology or R&D, Infrastructure
GTM typeB2B
B2B
Offering typeServices
Services
Core offering1 text field

Candesic is a London-based strategic consultancy delivering advisory services including corporate and divisional strategy, commercial due diligence, digital/AI consulting, tech-enabled strategic planning, and operations and clinical quality reviews. Services are tailored to corporates/operators, investors, and public sector organisations, with a particular focus on healthcare, social care, life sciences, and MedTech sectors. The firm combines multidisciplinary expertise (medical doctors, PhDs, MBAs, data scientists) with primary data collection capabilities to produce actionable strategic advice.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 value
  • Research study with College of Emergency Medicine found 85% of A&E attendees appropriately using emergency services, challenging official 40% figure cited in NHS policy documents
Product overview1 text field

Candesic is a strategic healthcare consultancy offering a unified portfolio of consulting services rather than a software product platform. The core offerings include Strategic Consulting, Commercial Due Diligence, Digital/AI Consulting, Tech-Enabled Strategic Planning, and Operations and Clinical Quality services. These services are delivered through multidisciplinary teams of approximately 40 professionals combining medical, scientific, business, and technology expertise. The consultancy serves clients across multiple sectors including Healthcare Services, Social Care, Pharma and Life Sciences, MedTech, and Digital & Software, providing CEO-level clarity with R&D-level insight to corporate teams, investors, and public sector organisations globally.

Product and service6 records
1Strategic Consulting
CategoryCore Consulting Service
Description

Strategic advisory service supporting corporate leaders in decision-making by setting corporate and divisional strategy, developing business plans, reviewing organic and inorganic growth road-maps, and analysing product positioning and competitive benchmarking. Targeted at corporates and operators ranging from startups to global multinationals.

2Commercial Due Diligence
CategoryCore Consulting Service
Description

Commercial due diligence services for divestiture, acquisition, or financing transactions, delivered to sellers, potential buyers, and financing sources under tight deadlines alongside investment teams. Targeted at investors including PE firms and corporate acquirers.

3Digital / AI Consulting
CategoryCore Consulting Service
Description

Consulting service focused on optimising processes and resources, and supporting the growth of emerging data-based companies. Works with established corporates to implement horizontal digital strategies leveraging AI, Machine Learning, data collection, and data analytics.

4Tech-Enabled Strategic Planning (Strategy-as-a-Service)
CategoryCore Consulting Service
Description

Innovative multi-year modular product combining virtual and in-person sessions to develop detailed strategic action plans, including financial planning forecasts. Jointly builds traditional strategic planning elements with senior managers as an ongoing engagement rather than a one-off project.

5Operations and Clinical Quality
CategoryCore Consulting Service
Description

Operational advisory service assisting clients in formulating operational plans following corporate events such as acquisition, divestiture, or restructuring. Reviews current organisational and operational structures and capabilities, identifying potential gaps.

6Scientific, Clinical and Operational Due Diligence
CategoryCore Consulting Service
Description

In-depth scientific, clinical, and operational due diligence for investors that translates critical technical concepts into business language for incorporation into decision frameworks. Targeted at investors evaluating healthcare and life sciences assets.

Scale indicator3 records

Each record includes

Type, Value, Description, Source

Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight5 records

Each record includes

Type, Description

Peers10 records
TypeBroad incumbent
Description

Top-tier global strategy firm with a leading healthcare practice and active private equity due diligence business. Multiple Candesic team members (Floris Wentholt, Dr Christopher Cassar) are former Bain consultants, and Bain is a direct competitor for healthcare strategy and PE value-creation work.

TypeDirect peer
Description

Global consulting firm with a healthcare and life sciences practice and a major transactions/due diligence franchise. Competes with Candesic on commercial and operational due diligence for healthcare PE deals across EMEA and the US.

TypeDirect peer
Description

US-headquartered healthcare-focused strategy consulting firm serving providers, payers and health technology companies. Closely comparable to Candesic given its healthcare-specialist positioning and strategic advisory focus.

TypeDirect peer
Description

Boutique healthcare and life sciences strategy consulting firm focused on MedTech, pharma, diagnostics and digital health. Comparable in size and specialisation to Candesic, with overlapping capabilities in commercial due diligence and growth strategy for healthcare investors.

TypeDirect peer
Description

Strategy and transactions arm of EY, one of the most active commercial due diligence providers to private equity. Dr Kristoffer Kenttä is a former EY senior consultant, and EY-Parthenon competes directly with Candesic for healthcare commercial and operational due diligence mandates.

6ZS Associates
TypeEmerging player
Description

Global consulting firm specialising in healthcare and life sciences, with deep expertise in pharma, MedTech and digital health. Competes with Candesic for healthcare strategy and commercial advisory engagements, particularly with pharma/biotech clients.

TypeBroad incumbent
Description

Largest global strategy consultancy with a substantial healthcare, life sciences and private equity practice. Both Candesic founders (Dr Leonid Shapiro, Marc Kitten) and partners (Aldous Mitchell) previously worked at McKinsey, and the firms compete on healthcare strategy and PE advisory mandates at the very top of the market.

TypeDirect peer
Description

Global strategy consulting firm with a deep healthcare and life sciences practice and one of the most active commercial due diligence franchises serving PE sponsors in healthcare. Jack Zeng started his career at L.E.K. before joining Candesic, and the firms compete head-to-head for healthcare strategy and CDD mandates.

TypeDirect peer
Description

Global management consultancy with a substantial healthcare and life sciences practice serving operators, insurers and PE sponsors. Overlaps directly with Candesic on healthcare strategy, commercial due diligence and value-creation mandates.

TypeBroad incumbent
Description

Global strategy consultancy with a large healthcare and biopharma practice that competes with Candesic for corporate strategy and growth advisory mandates across NHS-adjacent and life sciences clients in EMEA.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses4 records

Each record includes

Headline, Details, Source

Competitive moat5 records

Each record includes

Type, Details

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers4 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment3 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile3 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI capability3 records

Each record includes

Type, Description, Source

AI maturity
App detail

Has app

Feature3 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles10 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment1 record

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Candesic

Healthcare Management Consultingcandesic.com

Candesic is an independent London-headquartered healthcare strategy consultancy serving corporates, investors, and public sector organisations with strategic advisory, commercial due diligence, and digital/AI consulting, delivered by a ~40-person team of doctors, PhDs, and MBAs.

What Candesic does

Candesic is a London-headquartered, healthcare-specialist strategy consulting firm founded in 2002 by Dr Leonid Shapiro (formerly of McKinsey & Company). It serves three primary client segments — corporates and operators (from early-stage startups to global multinationals), investors across the investment lifecycle, and public sector organisations — across UK, EMEA, North America, and selected international markets. Services span strategic consulting (corporate/divisional strategy, growth roadmaps, M&A, pricing, regulatory), commercial due diligence for buy-side and sell-side transactions, scientific/clinical/operational due diligence, operations and clinical quality advisory, and digital/AI consulting.

The firm differentiates itself through a multidisciplinary team of ~40 professionals combining medical doctors, PhDs, and MBAs with international backgrounds, supported by in-house data scientists and programmers. Its methodology relies on creating proprietary primary datasets via Freedom of Information requests, panel surveys, and first-hand market information, and on a curated network of external thought leaders. It has delivered 700+ assignments over 20+ years and maintains offices in London and New York. The firm is independent and privately held (Candesic Limited, UK company number 11391257), with no disclosed institutional investors or parent entity.

Candesic firmographics

Firmographics
Name
Candesic
Legal name
Candesic Limited
Website
https://candesic.com
Company type
Private
Founded year
2002
Operating status
Operating
Headcount range
51–100 employees
Short description
Candesic is an independent London-headquartered healthcare strategy consultancy serving corporates, investors, and public sector organisations with strategic advisory, commercial due diligence, and digital/AI consulting, delivered by a ~40-person team of doctors, PhDs, and MBAs.
Ownership category
akta.pro rank

Candesic industry classification

Industry
Product category
Healthcare Management Consulting
NAICS
Management Consulting Services (54161), Management, Scientific, and Technical Consulting Services (5416)
SIC
Services-Management Consulting Services (8742)
akta.pro industry
PRIMARYBPAHADAN
Distressed M&A & Special Situations Advisory

Keywords

  • Healthcare consulting
  • Commercial due diligence
  • Strategic advisory services
  • Life sciences consulting
  • Digital health consulting

Where Candesic is headquartered

Location

Headquarters

HQ city
London
HQ country
United Kingdom
HQ region
Europe

Offices2 records

Markets served

Candesic business model

Business model
GTM type
B2B
Offering type
Services
Cost components
Personnel, Operations, Marketing or Sales, Technology or R&D, Infrastructure

Revenue model

  1. Strategic Consulting Services: Fees for strategic consulting including setting corporate and divisional strategy, developing business plans, reviewing organic and inorganic growth road-maps, analysing product positioning and providing competitive benchmarking. Services are provided to corporate teams, investors, and public sector organisations.

Go-to-market motion1 record

Distribution channels1 record

Marketing channels5 records

Candesic product offering

Product offering

Core offering

Candesic is a London-based strategic consultancy delivering advisory services including corporate and divisional strategy, commercial due diligence, digital/AI consulting, tech-enabled strategic planning, and operations and clinical quality reviews. Services are tailored to corporates/operators, investors, and public sector organisations, with a particular focus on healthcare, social care, life sciences, and MedTech sectors. The firm combines multidisciplinary expertise (medical doctors, PhDs, MBAs, data scientists) with primary data collection capabilities to produce actionable strategic advice.

Product overview

Candesic is a strategic healthcare consultancy offering a unified portfolio of consulting services rather than a software product platform. The core offerings include Strategic Consulting, Commercial Due Diligence, Digital/AI Consulting, Tech-Enabled Strategic Planning, and Operations and Clinical Quality services. These services are delivered through multidisciplinary teams of approximately 40 professionals combining medical, scientific, business, and technology expertise. The consultancy serves clients across multiple sectors including Healthcare Services, Social Care, Pharma and Life Sciences, MedTech, and Digital & Software, providing CEO-level clarity with R&D-level insight to corporate teams, investors, and public sector organisations globally.

Differentiator

Problem solved

Functional benefit

Products and services

  • Strategic Consulting Strategic advisory service supporting corporate leaders in decision-making by setting corporate and divisional strategy, developing business plans, reviewing organic and inorganic growth road-maps, and analysing product positioning and competitive benchmarking. Targeted at corporates and operators ranging from startups to global multinationals.
  • Commercial Due Diligence Commercial due diligence services for divestiture, acquisition, or financing transactions, delivered to sellers, potential buyers, and financing sources under tight deadlines alongside investment teams. Targeted at investors including PE firms and corporate acquirers.
  • Digital / AI Consulting Consulting service focused on optimising processes and resources, and supporting the growth of emerging data-based companies. Works with established corporates to implement horizontal digital strategies leveraging AI, Machine Learning, data collection, and data analytics.
  • Tech-Enabled Strategic Planning (Strategy-as-a-Service) Innovative multi-year modular product combining virtual and in-person sessions to develop detailed strategic action plans, including financial planning forecasts. Jointly builds traditional strategic planning elements with senior managers as an ongoing engagement rather than a one-off project.
  • Operations and Clinical Quality Operational advisory service assisting clients in formulating operational plans following corporate events such as acquisition, divestiture, or restructuring. Reviews current organisational and operational structures and capabilities, identifying potential gaps.
  • Scientific, Clinical and Operational Due Diligence In-depth scientific, clinical, and operational due diligence for investors that translates critical technical concepts into business language for incorporation into decision frameworks. Targeted at investors evaluating healthcare and life sciences assets.

Quantifiable outcome

  • Research study with College of Emergency Medicine found 85% of A&E attendees appropriately using emergency services, challenging official 40% figure cited in NHS policy documents

Companies that use Candesic

Customer profile

Named customers4 records

Segments3 records

Ideal customer profiles3 records

Candesic technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

AI capability3 records

Feature3 records

Candesic partnerships and signals

Strategic signal

Scale indicators3 records

Recent moves6 records

Expansion highlights5 records

Candesic competitors and assessment

Company assessment

Broad incumbents

  • Bain & Company: Top-tier global strategy firm with a leading healthcare practice and active private equity due diligence business. Multiple Candesic team members (Floris Wentholt, Dr Christopher Cassar) are former Bain consultants, and Bain is a direct competitor for healthcare strategy and PE value-creation work.
  • McKinsey & Company: Largest global strategy consultancy with a substantial healthcare, life sciences and private equity practice. Both Candesic founders (Dr Leonid Shapiro, Marc Kitten) and partners (Aldous Mitchell) previously worked at McKinsey, and the firms compete on healthcare strategy and PE advisory mandates at the very top of the market.
  • Boston Consulting Group: Global strategy consultancy with a large healthcare and biopharma practice that competes with Candesic for corporate strategy and growth advisory mandates across NHS-adjacent and life sciences clients in EMEA.

Direct peers

  • FTI Consulting: Global consulting firm with a healthcare and life sciences practice and a major transactions/due diligence franchise. Competes with Candesic on commercial and operational due diligence for healthcare PE deals across EMEA and the US.
  • The Chartis Group: US-headquartered healthcare-focused strategy consulting firm serving providers, payers and health technology companies. Closely comparable to Candesic given its healthcare-specialist positioning and strategic advisory focus.
  • Health Advances: Boutique healthcare and life sciences strategy consulting firm focused on MedTech, pharma, diagnostics and digital health. Comparable in size and specialisation to Candesic, with overlapping capabilities in commercial due diligence and growth strategy for healthcare investors.
  • EY-Parthenon: Strategy and transactions arm of EY, one of the most active commercial due diligence providers to private equity. Dr Kristoffer Kenttä is a former EY senior consultant, and EY-Parthenon competes directly with Candesic for healthcare commercial and operational due diligence mandates.
  • L.E.K. Consulting: Global strategy consulting firm with a deep healthcare and life sciences practice and one of the most active commercial due diligence franchises serving PE sponsors in healthcare. Jack Zeng started his career at L.E.K. before joining Candesic, and the firms compete head-to-head for healthcare strategy and CDD mandates.
  • Oliver Wyman: Global management consultancy with a substantial healthcare and life sciences practice serving operators, insurers and PE sponsors. Overlaps directly with Candesic on healthcare strategy, commercial due diligence and value-creation mandates.

Emerging players

  • ZS Associates: Global consulting firm specialising in healthcare and life sciences, with deep expertise in pharma, MedTech and digital health. Competes with Candesic for healthcare strategy and commercial advisory engagements, particularly with pharma/biotech clients.

Market position

Strengths5 records

Weaknesses4 records

Competitive moat5 records

Key highlights7 records

Customer concentration

Candesic social profiles

Digital presence

Candesic financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Candesic leadership team

Management profile

Number of profiles

Profiles10 records

Candesic funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Candesic M&A and investment

M&A and investment

M&A

Investments1 record

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Candesic

What does Candesic do?

Candesic is a London-based strategic consultancy delivering advisory services including corporate and divisional strategy, commercial due diligence, digital/AI consulting, tech-enabled strategic planning, and operations and clinical quality reviews. Services are tailored to corporates/operators, investors, and public sector organisations, with a particular focus on healthcare, social care, life sciences, and MedTech sectors. The firm combines multidisciplinary expertise (medical doctors, PhDs, MBAs, data scientists) with primary data collection capabilities to produce actionable strategic advice.

Is Candesic a public or private company?

Candesic is a private company. It is classified as founder individual operated bootstrapped and is currently operating.

When was Candesic founded?

Candesic was founded in 2002. It employs 51 to 100 people.

Where is Candesic based?

Candesic is headquartered in London, United Kingdom, in the Europe region.

How does Candesic make money?

One revenue line is on record: strategic Consulting Services.

Who are Candesic's main competitors?

Broad incumbents on record are Bain & Company, McKinsey & Company and Boston Consulting Group. Direct peers are FTI Consulting, The Chartis Group, Health Advances, EY-Parthenon, L.E.K. Consulting and Oliver Wyman. ZS Associates is listed as an emerging player.

Does Candesic have an API?

No public API is recorded for Candesic.

What industry is Candesic in?

Candesic's product category is Healthcare Management Consulting. Its primary akta.pro industry code is BPAHADAN, Distressed M&A & Special Situations Advisory. Its NAICS code is 54161 and its SIC code is 8742.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals